Apremilast Tablets IP 30 Mg - EPLENZA 30 Tablets

EPLENZA 30 Tablets
Composition: Apremilast 30 mg

EPLENZA 30 Tablets – Apremilast Tablets IP 30 mg contains Apremilast 30 mg, a targeted PDE4 inhibitor used for chronic inflammatory conditions such as psoriasis and psoriatic arthritis.
It works by regulating immune cell activity, reducing the release of pro-inflammatory cytokines, and minimizing skin plaques, swelling, and joint pain. With proven tolerability and a low risk of serious side effects, it is well-suited for long-term therapy and continuous symptom control.

Key Points of Amiodarone Hydrochloride Tablets 100Mg – ANACORON 100 Tablets

✅ Targeted Inflammation Relief – Reduces levels of cytokines such as TNF-α, IL-17, and IL-23, controlling excessive immune activity and inflammation.
✅ Oral Steroid-Free Therapy – Provides effective management of psoriasis and arthritis without the risks linked to long-term steroid use.
✅ Well-Tolerated for Long-Term Use – Requires minimal monitoring and offers a strong safety profile, making it ideal for chronic treatment.

Recommended by Specialists
👨‍⚕️Dermatologists
👨‍⚕️ Rheumatologists 
👨‍⚕️ Immunologists
👨‍⚕️ General Physicians 
👨‍⚕️ Healthcare practition

📢 Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.